Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Organic solute transporter subunit beta (SLC51B) is a single-pass transmembrane protein that partners with SLC51A (OSTα) to form the OSTα-OSTβ heterodimer. This transporter is essential for the basolateral export of bile acids, conjugated steroids, and prostaglandin E2 from epithelial cells, especially in the small intestine, liver, kidney, and other tissues involved in steroid and bile acid circulation. The SLC51A/SLC51B complex is required for normal bile acid absorption and dietary lipid uptake, acts independently of sodium, and is subject to adaptive transcriptional regulation in response to changes in bile acid load, often mediated via the FXR nuclear receptor. Mutations or absence of transporter function lead to profound alterations in bile acid and lipid metabolism. OSTβ is necessary for glycosylation and membrane targeting of OSTα, and both subunits must heterodimerize for stability and trafficking. Several clinically used drugs are known to inhibit OSTα/OSTβ-mediated transport. Increased expression of this transporter is found in cholestatic liver disease, supporting its role in hepatic bile acid adaptation and protection against toxicity.
Inhibition of bile acid and steroid conjugate efflux or uptake (by competitive blockade of the transporter); Modulation of intestinal/liver/kidney bile acid homeostasis; FXR-dependent transcriptional regulation alters transporter expression and function
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Organic solute transporter subunit beta (SLC51B).